MGMT promoter methylation, loss of expression and prognosis in 855 colorectal cancers.
about
TGFBR2 and BAX mononucleotide tract mutations, microsatellite instability, and prognosis in 1072 colorectal cancersMolecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and diseaseToward a Molecular Classification of Colorectal Cancer: The Role of MGMTColorectal carcinomas with KRAS mutation are associated with distinctive morphological and molecular featuresWhy do results conflict regarding the prognostic value of the methylation status in colon cancers? The role of the preservation method.Biomarker correlation network in colorectal carcinoma by tumor anatomic location.Expression of O(6)-methylguanine DNA methyltransferase (MGMT) and its clinical significance in gastroenteropancreatic neuroendocrine neoplasmPrognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinomaCorrelation of MLH1 and MGMT expression and promoter methylation with genomic instability in patients with thyroid carcinomaAltered expression of MGMT in high-grade gliomas results from the combined effect of epigenetic and genetic aberrations.Kras gene mutation and RASSF1A, FHIT and MGMT gene promoter hypermethylation: indicators of tumor staging and metastasis in adenocarcinomatous sporadic colorectal cancer in Indian populationRole of MGMT as biomarker in colorectal cancer.Clinicopathological significance and potential drug target of O6-methylguanine-DNA methyltransferase in colorectal cancer: a meta-analysis.Aberrant methylation patterns in cancer: a clinical view.Stratification and Prognostic Relevance of Jass's Molecular Classification of Colorectal Cancer.Human POLB gene is mutated in high percentage of colorectal tumors.Methylation of MGMT Is Associated with Poor Prognosis in Patients with Stage III Duodenal Adenocarcinoma.Clinical correlates of promoter hypermethylation of four target genes in head and neck cancer: a cooperative group correlative studyThe prognostic value of CDKN2A hypermethylation in colorectal cancer: a meta-analysis.DNA methylation patterns as noninvasive biomarkers and targets of epigenetic therapies in colorectal cancerPredictive and prognostic factors in colorectal cancer: a personalized approach.Molecular pathways involved in colorectal cancer: implications for disease behavior and preventionPromoter CpG island methylation markers in colorectal cancer: the road ahead.Epigenetic biomarkers in colorectal cancer diagnostics.Two DNA repair gene polymorphisms on the risk of gastrointestinal cancers: a meta-analysis.Prognostic value of MGMT methylation in colorectal cancer: a meta-analysis and literature review.Epigenetic CpG demethylation of the promoter and reactivation of the expression of Neurog1 by curcumin in prostate LNCaP cells.MGMT in colorectal cancer: a promising component of personalized treatment.Characterization of novel low passage primary and metastatic colorectal cancer cell lines.MGMT promoter methylation status in brain metastases from colorectal cancer and corresponding primary tumors.Epigenetics of colorectal cancer: emerging circulating diagnostic and prognostic biomarkers.Base excision repair imbalance in colorectal cancer has prognostic value and modulates response to chemotherapyDNA methylation of the p14ARF, RASSF1A and APC1A genes as an independent prognostic factor in colorectal cancer patientsMapping clinicopathological entities within colorectal mucinous adenocarcinomas: a hierarchical clustering approach.A study of the frequency of methylation of gene promoter regions in colorectal cancer in the Taiwanese population.Prognostic DNA methylation markers for sporadic colorectal cancer: a systematic review.Molecular epidemiology of and genetic susceptibility to esophageal cancer.Immunohistochemical staining for p16 and BRAFV600E is useful to distinguish between sporadic and hereditary (Lynch syndrome-related) microsatellite instable colorectal carcinomas.
P2860
Q24288715-78253F91-9357-4B0C-8AE2-FE24C8812978Q24289344-5B0C878B-B988-41A1-8A79-55027E27A137Q26862363-8CD0EC12-1276-43BC-858D-9FED0FB03B4DQ28284149-02C1A2C5-CDC4-484B-8595-99CBCBF96013Q31045418-E8A3CAF3-E630-4902-B92B-8A27FB397374Q33808553-C4E314D9-26E5-461A-B953-B75A6DE1F87FQ34029197-C6B3A8BC-E4B0-4A59-AEAC-1EEE16AF9D5AQ34486212-24150434-9728-41CF-B8C6-8134E7364D92Q34588501-5CC357EC-CAAC-4C44-B6C3-A9752D96CD50Q34625644-712A589D-7A24-47B8-8B46-F53DB76A0392Q34661887-466255E5-923A-45E1-8640-3EC542F848A7Q34706115-1579216E-845B-4E61-8253-8C5A1F31515FQ35567859-ECB86721-6766-438E-AB70-210781474342Q35750355-3A05BF51-35DA-41A7-BD01-73B5642E9ABCQ35971768-E38896FC-A9E6-45ED-B614-CDB543DAF62FQ36078847-B5DC7015-A0B3-4A66-A576-DB0D4FB8AD23Q36137083-69C22BB1-8BB5-470E-BBF5-9364E29D6D72Q36812119-04CF8B3A-4FE2-42D9-8D81-D547BED91E08Q36959134-80D89A19-D757-45CC-999D-C3C6535AE642Q37055333-75919C1C-0FF9-4203-917A-2E50803B028DQ37132653-86805ED8-50FB-4DB4-ADA1-913F6814D7ECQ37139174-153F5C08-AF66-4A23-844E-5EB3F2C52A0AQ37997086-80EDA063-0829-4E19-A70C-EB21DF63B805Q38018997-7533F38E-E921-443A-84ED-7ECE98C9D61AQ38160811-C23D4B06-444C-426C-9D9F-BC0F91DD8354Q38321611-B30AB293-3534-4016-9D9B-E7B784451F7CQ38331686-B419C3D7-AFFA-4EFC-8700-5401EE606ECAQ38783966-72569524-D6CF-4E19-9DC1-7116A1655B2FQ38792685-76CFFE46-42E6-456C-94C9-693892D2773AQ39022551-D2C3243B-4510-49EA-B146-5F0D5B5093BDQ41050138-2E3EA6D2-AD14-4916-BFCD-583403C897C0Q41552855-F03CAABB-0E17-4206-850E-D2329C3718AEQ42112284-B29D7E31-F090-45CC-AFA8-E154F59A57D6Q47787023-B2BF7F58-B5E0-4899-8880-B4888A29D068Q51022435-D04AA918-5F54-4AF5-8C16-B2AE3FF5B3BEQ52802632-56F97DB0-8EAF-42C6-A511-2D66750E8CBCQ53230220-7D17DBAA-07ED-4FCF-AA82-739BCEB18186Q54193016-80DE1E6B-19EC-4CC6-9C4D-2567B79BBDD0
P2860
MGMT promoter methylation, loss of expression and prognosis in 855 colorectal cancers.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
MGMT promoter methylation, loss of expression and prognosis in 855 colorectal cancers.
@ast
MGMT promoter methylation, loss of expression and prognosis in 855 colorectal cancers.
@en
type
label
MGMT promoter methylation, loss of expression and prognosis in 855 colorectal cancers.
@ast
MGMT promoter methylation, loss of expression and prognosis in 855 colorectal cancers.
@en
prefLabel
MGMT promoter methylation, loss of expression and prognosis in 855 colorectal cancers.
@ast
MGMT promoter methylation, loss of expression and prognosis in 855 colorectal cancers.
@en
P2093
P2860
P1476
MGMT promoter methylation, loss of expression and prognosis in 855 colorectal cancers.
@en
P2093
Kaori Shima
Katsuhiko Nosho
Mai Yamauchi
Maiko Suzuki
Marika Hayashi
Shuji Ogino
Teppei Morikawa
Yoshifumi Baba
P2860
P2888
P304
P356
10.1007/S10552-010-9698-Z
P577
2010-12-08T00:00:00Z